China issues guidelines for Shanghai international financial centre
The country will facilitate cross-border trade and investment and push for more international financial organisations to set up in Shanghai, the Central Financial Commission said in the guidelines.
China will also improve monitoring and alerting of cross-border capital flows, and take steps to prevent and defuse cross-border financial risks, according to the guidelines.
(Reporting by Beijing Newsroom Editing by Tomasz Janowski)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Zawya
7 hours ago
- Zawya
India, New Zealand wrap up second round of FTA talks, next round in September
India and New Zealand concluded the second round of free trade agreement talks in New Delhi on Friday, making progress in areas including goods, services, investment, and trade facilitation, India's commerce ministry said. The talks, held from July 14 to 25, follow the launch of negotiations in March during New Zealand Prime Minister Christopher Luxon's visit to India. The third round will be held in New Zealand in September, with virtual meetings planned before then. This comes a day after India signed a trade pact with Britain and as it continues negotiations with the European Union and the United States. Both sides aim to conclude a "balanced, comprehensive and forward-looking" deal, the ministry said in a statement. India's merchandise trade with New Zealand rose 48.6% year-on-year to $1.3 billion in the 2024/25 fiscal year that ended in March. The proposed deal is expected to boost trade, investment, and supply chain resilience. (Reporting by Manoj Kumar; Editing by Emelia Sithole-Matarise)
Zawya
9 hours ago
- Zawya
Shanghai Healthcare M&A Fund Takes Strategic Stake in MicroPort Scientific Corporation
HONG KONG SAR - Media OutReach Newswire - 25 July 2025 – MicroPort Scientific Corporation (Stock Code: "MicroPort") announced that Shanghai Healthcare M&A Fund ("SHMAF"), a fund managed by SIIC Capital, a subsidiary of SIIC Group, has entered into a share purchase agreement to acquire 135,335,204 shares in MicroPort held by Otsuka Medical Devices Co., Ltd. Through this transaction, SHMAF will become a strategic shareholder in MicroPort, underscoring its role as a state-backed, professionally operated platform that is creating value and empowering, stabilizing, developing, and reshaping leading biopharmaceutical companies in China. As a homegrown Chinese innovator that has grown into a global leader in high-end medical devices, MicroPort serves as an anchor company for the industry. Its stable development is critical to both China's and the global high-end medical device supply chain. This investment reflects SHMAF's capital-driven approach to providing crucial support to domestic anchor companies, ensuring their stability and support growth of their core assets. SHMAF will support MicroPort's growth momentum and high-quality sustainable development with its expansive resources. Introducing a strategic shareholder to drive growth momentum. The transaction brings in a significant strategic shareholder for MicroPort. Leveraging its state-backed resources and industrial expertise, SHMAF will support MicroPort's development needs, core business expansion, and potential strategic mergers and acquisitions to create synergies that bolster the company's ongoing innovation and scale-up its operations. Optimizing resource allocation to unlock synergistic value. MicroPort has successfully incubated and nurtured multiple listed companies and specialized, highly influential small companies, in the process establishing a unique MicroPort ecosystem. SHMAF will leverage its capital and operational integration expertise to support MicroPort in refining its development strategy, optimizing resource allocation, and unlocking synergistic value—while fully respecting market dynamics and corporate autonomy—to further strengthen its ecosystem and competitive advantages. Enhancing ecosystem to enhance anchor company value. MicroPort's product portfolio spans across ten major verticals, including cardiovascular intervention, rhythm management, orthopaedics, neurovascular intervention, and surgical robotics, making it a core player in the high-end medical device industrial chain. SHMAF's support will not only drive MicroPort's growth, it will also accelerate its consolidation of upstream and downstream companies in Shanghai, attract highly-skilled talent, and facilitate breakthroughs in critical technologies and core components—ultimately enhancing the global competitiveness of China's high-end medical device industry. This transaction marks another significant step in SHMAF's commitment to serving biopharmaceutical anchor companies. Upholding its value investment principles, SHMAF will collaborate with MicroPort's shareholders and management team to leverage the strategic support and industrial synergies its state-backed platform offers. Together, they will reinforce MicroPort's position as China's innovation engine in high-end medical devices and contribute to the advancement of the biopharmaceutical industry. Hashtag: #SIICCapital #MicroPort #SHMAF The issuer is solely responsible for the content of this announcement. About MicroPort Scientific Corporation Founded in 1998 and headquartered in Shanghai's Zhangjiang, MicroPort Scientific Corporation is a leading domestic innovative high-end medical device group. It began by breaking the import monopoly in the cardiovascular stent field, and after 26 years of innovative development, its business has expanded to areas including rhythm management, orthopaedics, cardiovascular intervention, aortic and peripheral vascular intervention, neurovascular intervention, heart valves, surgical robots, and surgical medical devices. By the end of 2024, MicroPort operated in over 20,000 hospitals across 100 countries and regions worldwide, providing more than 600 solutions for patients covering over 200 diseases. MicroPort has incubated 6 A-share and Hong Kong-listed companies, owns 9 specialized and sophisticated SMEs, 4 technology giant enterprises, and 16 national high-tech enterprises, making it an outstanding representative of Shanghai's technological innovation and industrial transformation. About SIIC Capital As the active fund management platform under SIIC Group, since its establishment, SIIC Capital has been based in Shanghai, connected with Hong Kong, and oriented towards the world, actively exploring investment opportunities in strategic emerging industries such as biomedicine and green environmental protection. Through a multi-currency, full-stage fund matrix layout, it deeply serves national strategies and the construction of biomedicine highlands. SIIC Capital
Arabian Business
9 hours ago
- Arabian Business
Abu Dhabi's AD Ports Group establishes its first international office in China
Giving further wings to its ambitious global expansion plans, Abu Dhabi-based AD Ports Group has officially launched its first international office in the Beijing-Tianjin area of China. The office, which adds to the Group's network of more than 140 offices worldwide, is located at the heart of China's policymaking and planning and will help coordinate the AD Port Group's commercial and investment activities across the country and the broader Asia region. AD Ports Group strengthens China presence A presence in China's capital will enable closer engagement with key government stakeholders, strategic partners, clients and investors, and help AD Ports Group align with the nation's development priorities and respond swiftly to emerging trade and logistics opportunities. Captain Mohamed Juma Al Shamisi, Managing Director and Group CEO, AD Ports Group, commented: 'As the world's largest exporter and driver of supply chain development, China is actively reshaping international trade. AD Ports Group shares China's vision for greater cross-border integration. 'Through our newly established Beijing office, we will work closely with our Chinese partners to support the expansion of key local, regional and international trade corridors and deliver cutting-edge shipping, infrastructure, and logistics solutions. 'We look forward to furthering our mutual investment flows and unlocking lasting value for our customers, investors and communities, creating a more connected, resilient and prosperous future for all.' The office will also play a key role in advancing the Group's presence domestically and along China's Belt and Road network, which includes maritime routes linking Asia, Africa, and Europe, and multimodal overland corridors connecting markets across several key markets. Noatum Logistics, the logistics arm for the Group, will also operate its new commercial branch for the Beijing-Tianjin region from the same office. As part of its China growth strategy, AD Ports Group will be expanding Noatum Logistics in-country capacities to offer a full suite of end-to-end logistics solutions tailored specifically to the needs of China's own rapidly expanding domestic market. The country's GDP is expected to grow at a CAGR of 3.5 per cent through 2030. With its logistics market projected to rise at a 4.6 per cent CAGR through 2030, the Group aims to become a major logistics player serving China's key industry sectors across their supply chain. The new office was officially opened by Samir Chaturvedi, Chief International Business Officer, AD Ports Group and CEO of Noatum Logistics; Abdulaziz Zayed Al-Shamsi, Regional CEO, AD Ports Group, and Ellie Hioe, General Manager of Noatum Logistics – Greater China. The launch builds on the Group's long-standing partnerships with Chinese businesses. Specifically, the Group and Jiangsu Overseas Cooperation Investment operate one of the most successful economic zones in Abu Dhabi, while COSCO Shipping Ports (CSP) operates a major container terminal via a joint venture at Khalifa Port. A growing number of Chinese companies have invested in manufacturing and trading entities within KEZAD, the largest operator of integrated economic zones in the UAE.
